window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : April 20, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Regulatory Compliance

  • Biomanufacturing,CDMOs & Manufacturing,Regulatory Affairs,Supply Chain & Logistics

    Drug Association to host sustainable packaging innovation workshop at Pharmapack Europe 2026

    The Parenteral Drug Association will host a half-day workshop focused [...]

    January 21, 2026
  • Artificial Intelligence,Clinical Trials,Data Management,Drug Development,Technology and platforms

    Agentic AI in pharma and how it could transform clinical trials

    Prasanna Rao, Chief Products and Innovation Officer at Saama, explains [...]

    October 12, 2025
  • Clinical Trials,Data Management,Drug Development,Medical devices,Technology and platforms

    Arkivum partners with PHARMASEAL to enhance unified trial management platform

    Arkivum has announced a partnership with PHARMASEAL, provider of the [...]

    September 23, 2025
  • Artificial Intelligence,Medical devices,Regulatory Affairs

    Artificial intelligence: survey finds medical device industry slow to adopt AI in product operation

    A new survey has found that medical device companies are [...]

    August 20, 2025
  • Clinical Development,Oncology,Partnerships & Funding,Regulatory Affairs,Research & Development,Technology and platforms

    Start and Advarra unite to accelerate early-phase oncology trials with integrated technology

    The START Center for Cancer Research has formed a strategic [...]

    July 25, 2025
  • Artificial Intelligence,Clinical Development,Pharmacovigilance,Regulatory Affairs,Research & Development

    Pistoia Alliance expands into pharmacovigilance space with launch of two new initiatives

    Collaboration efforts aim to reduce manual burden of adverse event [...]

    July 22, 2025
  • Artificial Intelligence,Technology and platforms

    Wiley and Anthropic partner to embed peer-reviewed research into AI workflows

    Integration of Model Context Protocol aims to ensure responsible, citation-based [...]

    July 14, 2025
  • Artificial Intelligence,Market Access & Commercialization,Regulatory Affairs,Supply Chain & Logistics,Technology and platforms

    From tariffs to AI: Why pharma procurement needs a rethink

    As global trade policies shift and compliance pressures mount, pharma [...]

    July 7, 2025
  • CDMOs & Manufacturing,Drug Development,Regulatory Affairs,Technology and platforms

    Thermo Fisher upgrades charged aerosol detection tech to improve complex drug analysis

    Thermo Fisher Scientific has introduced a new version of its [...]

    July 2, 2025
  • Biologics & Biosimilars,CDMOs & Manufacturing,Cell & Gene Therapy,Partnerships & Funding,Regulatory Affairs

    Unlocking collective intelligence: Why cell and gene therapy needs a data-sharing revolution

    Alexander Seyf, CEO of Autolomous, explains how collaboration—not competition—is the [...]

    June 10, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma publishes real-world CHRONOS data in third-line acute GvHD
    Categories: Clinical Development, Clinical studies, Hematology, Regulatory Affairs, Research & Development
  • Symbiosis expands QC capabilities with new 30°C stability chamber
    Categories: CDMOs & Manufacturing, Facilities and infrastructure, Manufacturing, Pharmaceuticals and therapeutics
  • Kainova expands Phase 1/2 trial of DT-7012 with first European patient dosed
    Categories: Clinical Trials, Immunology, Oncology, Research & Development
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top